"At Ascada Research, we are dedicated to the advancement of the medical sciences and the safety of medications used to treat disease. It is the highest honor to take part in the movement of improving the human condition. We maintain the highest standards of care and look for trials that make the biggest, positive impact."

During the past decade, Ascada Research conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascada Research" #1 collaborator was "Molecular Partners AG" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ascada Research" are "COVID-19" (3 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Clostridioides Difficile Infection" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Ascada Research" in a lesser frequency.

Most popular intervention types in "Ascada Research" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "PF-07321332" (2 trials), "Ritonavir" (2 trials), "Active Comparator" (1 trials) and "CRS3123" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ascada Research" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ascada Research". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ascada Research, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ascada Research, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".